FOXO1 and neoplasm: FOXO1i and FOXO1KO cells also exhibited attenuated killing and/or cytokine secretion after tumour challenge (Fig 1f and Extended Data Fig. 1f,g), consistent with a model in which FOXO1 restrains exhaustion and/or terminal differentiation in human T cells, similar to reports in mice14,19–22.